DM-Pharma SRL
DM-Pharma reported total assets of 217,870 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jun 2026).
The score of DM-Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity 0 % Total assets +7 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
DM-Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 21 Jun 2025
- Year ended 31 Dec 2023filed on 23 Aug 2024
- Year ended 31 Dec 2022filed on 30 Jun 2023
- Year ended 31 Dec 2021filed on 27 Jun 2022
DM-Pharma's financial analysis
- Solvency22.7%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of DM-Pharma
DM-Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0760.881.856
- VAT number
- BE0760881856
- Peppol
- Registered · 0208:0760881856 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 Jan 2021
- Registered office
- 9400 Ninove
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
DM-Pharma (SRL) has been based in Ninove since 2021, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 851 € and equity of 49,542 €; its revenue is not published. Its solvency stands at 22.7%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to DM-Pharma
Companies in the same business, of comparable size and area, outside its group.
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- White-to-Black Retail sale of pharmaceutical products Dilbeek · balance sheet 209,334 €
- Farmafender Retail sale of pharmaceutical products Zedelgem · balance sheet 269,880 €
- Liwoma Retail sale of pharmaceutical products Kontich · balance sheet 289,010 €
- De Groene WEG Retail sale of pharmaceutical products Ranst · balance sheet 189,429 €
- Sarina Janssens Farma Retail sale of pharmaceutical products Bierbeek · balance sheet 136,654 €
- Karbon Plus Retail sale of pharmaceutical products Diksmuide · balance sheet 127,790 €
- Apocurae Retail sale of pharmaceutical products Kortemark · balance sheet 124,948 €
Frequently asked questions about DM-Pharma
What is the revenue of DM-Pharma?
DM-Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of DM-Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0760881856 for DM-Pharma, if the company is VAT-registered. Its company number (CBE) is 0760.881.856.
Where is the registered office of DM-Pharma?
According to the CBE register, the registered office of DM-Pharma is in 9400 Ninove.
What is the equity of DM-Pharma?
At the close of the 2025 financial year, the equity of DM-Pharma amounts to 49,542 €, a solvency of 22.7% of total assets.
Who manages DM-Pharma?
The register lists 1 active mandates at DM-Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of DM-Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →